COVID-19 vaccine: Bharat Biotech’s COVAXIN gets nod for phase 2/3 trials on 2-18 years old

The clinical trials for the vaccine will take place in 525 subjects at different sites, including AIIMS, Patna, AIIMS, Delhi, and Meditrina Institute of Medical Sciences, Nagpur.

from Jagran Josh https://ift.tt/3vZ97nZ